NorthShore University HealthSystem

Miller Law LLC Announces A Proposed Settlement With NorthShore University HealthSystem If You Paid For Inpatient Hospital Services from February 10, 2000, to December 31, 2015

Retrieved on: 
Wednesday, February 14, 2024
Class, NorthShore University HealthSystem, Court, Hearing, Settlement, ENH, Health insurance

If you paid for Inpatient Hospital Services at NorthShore University HealthSystem (or Evanston Northwestern Healthcare), you Could Get Money from a Settlement.

Key Points: 
  • If you paid for Inpatient Hospital Services at NorthShore University HealthSystem (or Evanston Northwestern Healthcare), you Could Get Money from a Settlement.
  • Your rights may be affected by a proposed Settlement in a class action lawsuit with NorthShore University HealthSystem ("NorthShore"), which used to be called Evanston Northwestern Healthcare Corporation ("ENH").
  • The lawsuit claims that NorthShore overcharged purchasers for inpatient healthcare services after it merged with Highland Park Hospital.
  • You may have seen a previous notice that stated purchasers of outpatient hospital services were included in the Class.

Miller Law LLC Announces A Proposed Settlement With NorthShore University HealthSystem If You Paid For Inpatient Hospital Services from February 10, 2000, to December 31, 2015

Retrieved on: 
Wednesday, February 14, 2024
Class Action Lawsuit, Professional Services, Legal, Court, Hearing, Class, ENH, NorthShore University HealthSystem, Settlement, Health insurance

If you paid for Inpatient Hospital Services at NorthShore University HealthSystem (or Evanston Northwestern Healthcare), you Could Get Money from a Settlement.

Key Points: 
  • If you paid for Inpatient Hospital Services at NorthShore University HealthSystem (or Evanston Northwestern Healthcare), you Could Get Money from a Settlement.
  • Your rights may be affected by a proposed Settlement in a class action lawsuit with NorthShore University HealthSystem (“NorthShore”), which used to be called Evanston Northwestern Healthcare Corporation (“ENH”).
  • The lawsuit claims that NorthShore overcharged purchasers for inpatient healthcare services after it merged with Highland Park Hospital.
  • You may have seen a previous notice that stated purchasers of outpatient hospital services were included in the Class.

Oral Presentation at American Heart Association’s Scientific Sessions Highlights the Need for Esophageal Protection During Ablation

Retrieved on: 
Monday, November 13, 2023
Research, FDA, Clinical Trials, Health Technology, Cardiology, Biotechnology, Pharmaceutical, Health, Science, Other Science, Atrial fibrillation, De novo, Risk, AHA, Fistula, Database, Patient, Fatality, Cardiac electrophysiology, Trial of the century, NorthShore University HealthSystem, FHRS, University, American Heart, Injury, Liquor, MD

An oral presentation at the American Heart Association’s Scientific Sessions examined recent reporting rates of esophageal injury after left atrial ablation for the treatment of atrial fibrillation and found that the rates have not decreased in the last four years.

Key Points: 
  • An oral presentation at the American Heart Association’s Scientific Sessions examined recent reporting rates of esophageal injury after left atrial ablation for the treatment of atrial fibrillation and found that the rates have not decreased in the last four years.
  • The presentation at AHA by Christopher Joseph, MD (University of Texas, Southwestern Medical Center, Dallas, TX, USA) during the session Rapid Fire: More Sessions on Atrial Fibrillation Ablation.. Get Ready!!
  • reviewed data from the Manufacturer and User Facility Device Experience (MAUDE) database.
  • Reported fatality rates remain high at 41 percent.

NorthShore - Edward-Elmhurst Health is Now Endeavor Health

Retrieved on: 
Tuesday, December 5, 2023
Magnet, Orthopedic surgery, Research, Primary care, Circulatory system, FAQ, Patient, North Star Bicycle Festival, Trust, Health, Swedish Hospital, Neuroscience, NorthShore University HealthSystem, North, Hospital, Physician, Name, Nursing, Cancer

EVANSTON, Ill., Dec. 5, 2023 /PRNewswire/ -- NorthShore – Edward-Elmhurst Health today revealed the name and unified brand for its newly combined health system: Endeavor Health℠.

Key Points: 
  • EVANSTON, Ill., Dec. 5, 2023 /PRNewswire/ -- NorthShore – Edward-Elmhurst Health today revealed the name and unified brand for its newly combined health system: Endeavor Health℠.
  • This announcement marks an exciting milestone following the merger between NorthShore University HealthSystem (NorthShore), including Swedish Hospital and Northwest Community Healthcare and Edward-Elmhurst Health, creating the third largest health system in Illinois serving an area of 4.2 million residents.
  • "Both inspirational and aspirational, Endeavor Health embodies our mission to help everyone in our communities be their best," said J.P. Gallagher, President and Chief Executive Officer, Endeavor Health.
  • Advancing the health, wellbeing and economic security of the communities it serves will be an enduring focus for Endeavor Health.

Densitas Unveils intelliMaven™ at RSNA: Your NextGen AI Solution for Mammography Quality Assurance

Retrieved on: 
Thursday, November 16, 2023
Radiology, RSNA, Structural load, Annual general meeting, Language, Breast cancer, Mammography, Nextgen, FDA, Intelligence, Accreditation, Job satisfaction, NS, Software, NorthShore University HealthSystem, ACR, Medical imaging

HALIFAX, NS, Nov. 16, 2023 /PRNewswire/ - Densitas®, a global leader in artificial intelligence solutions for breast cancer screening, announces the launch of intelliMaven™, a groundbreaking NextGen AI solution for mammography.

Key Points: 
  • HALIFAX, NS, Nov. 16, 2023 /PRNewswire/ - Densitas®, a global leader in artificial intelligence solutions for breast cancer screening, announces the launch of intelliMaven™, a groundbreaking NextGen AI solution for mammography.
  • Set to be featured at the Radiological Society of North America (RSNA) 2023 Annual Meeting, intelliMaven™ is poised to transform the way mammography quality assurance is delivered and provide a scalable and sustainable quality assurance solution for mammography facilities to meet FDA MQSA EQUIP compliance and ACR accreditation requirements.
  • It automates advanced analytics, turning intricate data patterns and trends into clear accessible language that empower users to unlock the full potential of their data.
  • Paired with Densitas' flagship product intelliMammo®, intelliMaven™ is set to revolutionize mammography quality improvement with a sustainable, resource-efficient approach that is accessible to all.

Densitas Unveils intelliMaven™ at RSNA: Your NextGen AI Solution for Mammography Quality Assurance

Retrieved on: 
Thursday, November 16, 2023
Radiology, RSNA, Structural load, Annual general meeting, Language, Breast cancer, Mammography, Nextgen, FDA, Intelligence, Accreditation, Job satisfaction, NS, Software, NorthShore University HealthSystem, ACR, Medical imaging

HALIFAX, NS, Nov. 16, 2023 /PRNewswire/ -- Densitas®, a global leader in artificial intelligence solutions for breast cancer screening, announces the launch of intelliMaven™, a groundbreaking NextGen AI solution for mammography.

Key Points: 
  • HALIFAX, NS, Nov. 16, 2023 /PRNewswire/ -- Densitas®, a global leader in artificial intelligence solutions for breast cancer screening, announces the launch of intelliMaven™, a groundbreaking NextGen AI solution for mammography.
  • Set to be featured at the Radiological Society of North America (RSNA) 2023 Annual Meeting, intelliMaven™ is poised to transform the way mammography quality assurance is delivered and provide a scalable and sustainable quality assurance solution for mammography facilities to meet FDA MQSA EQUIP compliance and ACR accreditation requirements.
  • It automates advanced analytics, turning intricate data patterns and trends into clear accessible language that empower users to unlock the full potential of their data.
  • Paired with Densitas' flagship product intelliMammo®, intelliMaven™ is set to revolutionize mammography quality improvement with a sustainable, resource-efficient approach that is accessible to all.

Study Shows First-Ever Successful Deep-Brain Implant of Computer Chip in Living Animal

Retrieved on: 
Tuesday, October 31, 2023
Stroke, Intelligence, ICH, MIPS, Pearson, MD, Infection, BCI, NICO, Health, MIS, ENRICH, DSM-IV codes, Myenteric plexus, IC, Medicine, Neuroscience, Brain, Neurosurgery, Interface (computing), NorthShore University HealthSystem, The Wall Street Journal, Medical device, Medical imaging

INDIANAPOLIS, Oct. 31, 2023 /PRNewswire/ -- A first study demonstrating successful deep-brain placement of a brain computer interface microchip into a living animal with no apparent neurological effects is now published from Julian E. Bailes, MD, a recognized leader in the field of neurosurgery and co-director of the NorthShore University HealthSystem. Dr. Bailes' work has addressed the long-standing challenge of safely accessing subcortical regions of the brain for the purpose of microchip implantation without disrupting surrounding tissue.

Key Points: 
  • First study of successful deep-brain implant of computer could lead to new treatments for many neurological disorders.
  • "This study had two intentions," Dr. Bailes explained.
  • The use of brain-computer interface (BCI) technologies is a rapidly developing area of interest in neurosurgery and medicine as a whole.
  • Its technologies have been featured in more than 180 peer-reviewed published papers with over 550 unique authors from major academic centers.

Study Finds Significant Reduction in Esophageal Injury Rate When Using ensoETM™ During Cardiac Radiofrequency Ablation Procedures

Retrieved on: 
Monday, September 25, 2023
Science, Other Science, Biotechnology, Research, General Health, Health, Clinical Trials, Other Health, Radiation, FHRS, De novo, Atrial fibrillation, Esophageal disease, Esophagus, Multimedia, Temperature, Massage chair, AEF, NorthShore University HealthSystem, Cardiac electrophysiology, Hospital, AEF Monotrace, Journal, Patient, Fluoroscopy, Sutter Health, American College, Death, Liquor, Medical device, Doctor of Philosophy, MD

Esophageal injury can occur during ablation procedures for the treatment of atrial fibrillation, and an AEF is the most severe form of injury, resulting in death in most cases.

Key Points: 
  • Esophageal injury can occur during ablation procedures for the treatment of atrial fibrillation, and an AEF is the most severe form of injury, resulting in death in most cases.
  • View the full release here: https://www.businesswire.com/news/home/20230925491005/en/
    A peer-reviewed study in the Journal of the American College of Cardiology: Clinical Electrophysiology (JACC-EP) has found a significant reduction in the rate of atrioesophageal fistulas (AEFs) during cardiac ablation of the left atrium when using Attune Medical’s ensoETM proactive esophageal cooling device compared to luminal esophageal temperature monitoring.
  • The authors concluded that adoption of active esophageal cooling during RF ablation of the left atrium for the treatment of atrial fibrillation was associated with a significant reduction in AEF rate.
  • “This is the first study of the effectiveness of any technique to show a significant benefit in the reduction of AEFs.

Attune Medical’s ensoETM™ Granted FDA De Novo Marketing Authorization to Reduce the Likelihood of Ablation-related Esophageal Injury Resulting from Radiofrequency Cardiac Ablation Procedures

Retrieved on: 
Thursday, September 14, 2023
Science, Cardiology, Biotechnology, Research, Health, FDA, Clinical Trials, Other Health, Medicine, US Foods, FHRS, De novo, Atrial fibrillation, Esophagus, Multimedia, Temperature, AEF, NorthShore University HealthSystem, Cardiac electrophysiology, Operating, Hospital, Journal, Patient, Physician, Risk, Electrophysiology, IMPACT, Fluoroscopy, American College, Safety, Medical device, Pharmaceutical industry, MD

Attune Medical has been granted De Novo marketing authorization from the US Food and Drug Administration (FDA) for its ensoETM device to reduce the likelihood of ablation-related esophageal injury resulting from radiofrequency cardiac ablation procedures.

Key Points: 
  • Attune Medical has been granted De Novo marketing authorization from the US Food and Drug Administration (FDA) for its ensoETM device to reduce the likelihood of ablation-related esophageal injury resulting from radiofrequency cardiac ablation procedures.
  • View the full release here: https://www.businesswire.com/news/home/20230914650329/en/
    Attune Medical has been granted De Novo marketing authorization from the US Food and Drug Administration (FDA) for its ensoETM device to reduce the likelihood of ablation-related esophageal injury resulting from radiofrequency cardiac ablation procedures.
  • It is the most common type of cardiac ablation procedure, with over 300,000 per year performed in the US alone.
  • This De Novo marketing authorization expands the ensoETM’s indications for use to reduce the likelihood of esophageal injury resulting from radiofrequency cardiac ablation procedures.

SPR Therapeutics Announces 20,000th Patient Implant of SPRINT® PNS System

Retrieved on: 
Tuesday, August 22, 2023
Travel, Life, American Board of Preventive Medicine, SPR, Nurses Improving Care for Healthsystem Elders, Quality of life, PNS, Pain, American Board of Commissioners for Foreign Missions, Addiction medicine, Pain management, Patient, Data, Love, NorthShore University HealthSystem, Growth, Therapy, Chronic pain, SPRINT, Dentistry, Medical device, Pharmaceutical industry, MD

CLEVELAND, Aug. 22, 2023 (GLOBE NEWSWIRE) -- SPR® Therapeutics, a private medical device company focused on treating pain and improving the quality of life for patients managing acute or chronic pain, announced the 20,000th patient implant of the SPRINT® PNS System.

Key Points: 
  • CLEVELAND, Aug. 22, 2023 (GLOBE NEWSWIRE) -- SPR® Therapeutics, a private medical device company focused on treating pain and improving the quality of life for patients managing acute or chronic pain, announced the 20,000th patient implant of the SPRINT® PNS System.
  • Since its commercialization six years ago in July 2017, many pain specialists have utilized the SPRINT PNS system as a new approach to offer their patients a less-invasive, 60-day treatment that does not require a permanent implant.
  • The outcomes of real-world applications are a strong supplement to patient experience in clinical trials as the population is broader and more diverse.
  • She also holds a board certification in Addiction Medicine from the American Board of Preventive Medicine and performed the very first commercial implant of the SPRINT PNS System in 2017 along with implanting the 20,000th patient.